Table 1.
Participant | Colonization site | AB resistance | PVL | spa type |
---|---|---|---|---|
1 | Throat | P | − | t008 |
2 | Nose | P | − | t078 |
3 | Throat | None | − | t216 |
4 | Nose | P, E, TMP-SMX | − | t1892 |
5 | Nose | None | − | t012 |
5 | Throat | None | − | t4032 |
6 | Nose | P | + | t2104 |
7 | Throat | P | + | t2104 |
8 | Throat | P | + | t4106 |
9 | Throat | P | + | t021 |
10 | Nose | P | + | t015 |
11 | Nose | P | − | t021 |
12 | Nose | P | + | t021 |
12 | Throat | None | + | t021 |
13a | Nose | P | − | t216 |
14 | Nose | None | − | t233 |
15 | Throat | None | + | t3274 |
16 | Nose | None | + | t008 |
17 | Nose | TMP-SMX | − | t037 |
17 | Throat | None | − | t037 |
18 | Nose | None | − | t021 |
19 | Nose | None | − | t037 |
20 | Nose | None | + | t279 |
20 | Throat | None | + | t279 |
21 | Nose | None | − | t359 |
22 | Throat | None | − | t2612 |
23 | Nose | None | − | t209 |
23 | Throat | None | − | t209 |
24 | Throat | TMP-SMX | − | t024 |
25 | Nose | None | − | t084 |
26 | Nose | E, C, L | − | t002 |
27 | Nose | None | − | t548 |
28 | Nose | None | − | t4158 |
29 | Nose | None | − | t162 |
30 | Nose | E, IC | − | t002 |
31 | Nose | None | − | t021 |
Penicillin resistance testing was discontinued after this isolate.
PVL, Panton-Valentine leukocidin; P, penicillin resistance; E, erythromycin resistance; TMP-SMX, trimethoprim-sulfamethoxazole resistance; C, clindamycin resistance; L, levofloxacin resistance; IC, inducible clindamycin resistance.